Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;107:1146-1151
Published online before print February 10, 2003, doi: 10.1161/01.CIR.0000051461.92839.F7
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
107/8/1146    most recent
01.CIR.0000051461.92839.F7v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Terry, J. G.
Right arrow Articles by Crouse, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Terry, J. G.
Right arrow Articles by Crouse, J. R., III
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Coronary Artery Disease
Related Collections
Right arrow Remodeling
Right arrow Carotid Stenosis
Right arrow Doppler ultrasound, Transcranial Doppler etc.
Right arrow Chronic ischemic heart disease
Right arrow Epidemiology

(Circulation. 2003;107:1146.)
© 2003 American Heart Association, Inc.


Clinical Investigation and Reports

Carotid Arterial Structure in Patients With Documented Coronary Artery Disease and Disease-Free Control Subjects

James G. Terry, MS; Rong Tang, MD; Mark A. Espeland, PhD; Donna H. Davis, BS; Jose L.C. Vieira, MD, PhD; Michele F. Mercuri, MD, PhD; John R. Crouse, III, MD

From the Departments of Internal Medicine (J.G.T., D.H.D, J.L.C.V., J.R.C.), Division of Vascular Ultrasound Research (R.T., M.F.M.), and Public Health Sciences (M.A.E., J.R.C.), Wake Forest University School of Medicine, Winston-Salem, NC. Dr Mercuri is currently employed by Merck & Co Inc, Rahway, NJ.

Correspondence to John R. Crouse III, MD, Department of Internal Medicine/Endocrinology, Wake Forest University School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157-1047. E-mail jrcrouse{at}wfubmc.edu

Background— Although atherosclerosis often leads to lumen narrowing and symptomatic cardiovascular disease, it is now recognized that arteries have the potential to compensate by enlarging in response to atherosclerosis. We tested the hypotheses that carotid arterial interadventitial (IA) and lumen diameters were related to wall thickness and that carotid arterial diameters of individuals with coronary artery disease (CAD) differed from those of CAD-free controls.

Methods and Results— We measured lumen diameter, IA diameter, and intima-media thickness (IMT) using B-mode ultrasound in the common and internal carotid arteries of 141 CAD case patients and 139 disease-free control subjects. Common carotid IA diameter was greater in CAD cases than controls after adjustment for age, height, and sex (P<0.01). Common carotid lumen diameter was marginally larger in individuals with greater IMT (P=0.06) but was not associated with case status. Conversely, mean internal carotid IA and lumen diameters were smaller in CAD cases than controls in both univariable and multivariable models (both P<0.001), and lumina were smaller in individuals with greater IMT. Despite these cross-sectional differences in carotid artery dimensions, we were unable to detect any statistically significant interactive effects of CAD case status on the association of IMT with arterial dimensions.

Conclusions— Internal carotid artery lumen and IA diameters are both smaller in CAD cases than controls. The association of increased IMT with arterial dimensions varies in a manner that is segment-specific for the common and internal carotid arteries.


Key Words: carotid arteries • atherosclerosis • coronary disease • compensation




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
E. Ruiz, S. Redondo, A. Gordillo-Moscoso, and T. Tejerina
Pioglitazone Induces Apoptosis in Human Vascular Smooth Muscle Cells from Diabetic Patients Involving the Transforming Growth Factor-beta/Activin Receptor-Like Kinase-4/5/7/Smad2 Signaling Pathway
J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 431 - 438.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. R. Crouse III
Thematic review series: Patient-Oriented Research. Imaging atherosclerosis: state of the art
J. Lipid Res., August 1, 2006; 47(8): 1677 - 1699.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. Ruiz, A. Gordillo-Moscoso, E. Padilla, S. Redondo, E. Rodriguez, F. Reguillo, A. M. Briones, C. van Breemen, E. Okon, and T. Tejerina
Human vascular smooth muscle cells from diabetic patients are resistant to induced apoptosis due to high bcl-2 expression.
Diabetes, May 1, 2006; 55(5): 1243 - 1251.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. L. Bots, D. E. Grobbee, A. Hofman, and J. C.M. Witteman
Common Carotid Intima-Media Thickness and Risk of Acute Myocardial Infarction: The Role of Lumen Diameter
Stroke, April 1, 2005; 36(4): 762 - 767.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. M.A. Henry, P. J. Kostense, J. M. Dekker, G. Nijpels, R. J. Heine, O. Kamp, L. M. Bouter, and C. D.A. Stehouwer
Carotid Arterial Remodeling: A Maladaptive Phenomenon in Type 2 Diabetes but Not in Impaired Glucose Metabolism: The Hoorn Study
Stroke, March 1, 2004; 35(3): 671 - 676.
[Abstract] [Full Text] [PDF]